-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.P1.64 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Stephanie Fingerson1*, Yung-Tsi Bolon, PhD1*, Steven M Devine, MD2 and Stephen R. Spellman1*

1CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
2Center For International Blood and Marrow Transplant Research, Minneapolis, MN

Haitao Wang*, Liping Dou*, Lili Wang*, Bo Peng*, Nan Wang*, Yingxin Zhao*, Jishan Du* and Daihong Liu, MD

Department of Hematology, Chinese PLA General Hospital, Beijing, China

Marie Luise Hütter-Krönke, MD1*, Adela Neagoie, MD2*, Igor Wolfgang Blau, MD3*, Lam Giang Vuong4*, Maral Saadati, PhD5*, Axel Benner6*, Lars Bullinger, MD7, Hartmut Döhner, MD2, Donald Bunjes, MD8* and Elisa Sala, MD2*

1Department of Hematology, Oncology and Tumorimmunology, Charité- Universitätsmedizin Berlin, Berlin, AL, Germany
2Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
3Department of BMT, Clinic of Hematology, Oncology and Tumorimmunology, University Medicine Berlin, Berlin, Germany
4Department of Hematology, Oncology and Tumorimmunology, Charité- Universitätsmedizin Berlin, Berlin, Germany
5Saadati Solutions, Ladenburg, Germany
6Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
7Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Berlin, Germany
8Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew L. Pecora, MD2*, Andrew Ip, MD, MSc3,4, Andre H. Goy, MD, MS5*, Spiraggelos Antzoulatos1*, Wanlong Ma1*, Sukhdeep Kaur, MD6*, Hyung C. Suh, MD, PhD6*, Michele L. Donato, MD2* and Scott D. Rowley, MD2

1Genomic Testing Cooperative, Irvine, CA
2John Theurer Cancer Center, Hackensack Meridian Health, Division of Multiple Myeloma, Hackensack, NJ
3Hackensack Meridian Health Hackensack University Medical Center, Hackensack, NJ
4Division of Lymphoma, Division of Outcomes and Value Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
5Hackensack Meridian School of Medicine, Hackensack, NJ
6John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

Susan DeWolf, MD1, Jason Kuttiyara2*, Paola Vinci, PhD2*, John Slingerland2*, Leeann T. Marcello2*, Paul A. Giardina2*, William Donohoe2*, Richard J. Lin, MD3,4, Esperanza B. Papadopoulos, MD3,4, Boglarka Gyurkocza, MD3,4, Brian C. Shaffer, MD3,4, Martin S. Tallman, MD1,4, Sergio A. Giralt, MD, FACP, FASTCT4,5*, Ioannis Politikos, MD3,4, Juliet N. Barker, MBBS3,4, Roni Tamari, MD3,4, Christina Cho, MD3,4, Miguel-Angel Perales, MD3,4, Marcel R M van den Brink, MD, PhD3,4 and Alan M. Hanash, MD3,4

1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Medicine, Weill Cornell Medical College, New York, NY
5Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

Nicoletta Cieri, MD, PhD1,2,3*, Nidhi Hookeri, MS1,2*, Kari Stromhaug, BS1,2*, Jonathan Stevens, MS4*, Kameron Kooshesh, MD3,5*, Susan Klaeger2*, Karl R Clauser, BS2*, Siranush Sarkizova, PhD2*, David A Braun, MD, PhD6*, Livius Penter, MD1,2,3, Giacomo Oliveira, PhD1,3*, Haesook T Kim, PhD1,7, William J Lane, MD, PhD4, Shuqiang Li, PhD1,2,8*, Kenneth J Livak, PhD1,8*, Vincent T Ho, MD3,9,10*, Jerome Ritz, MD, PhD1,3,10, Robert J Soiffer, MD3,9,10, Derin B Keskin, PhD1,2,8,11,12*, Chip Stewart, PhD13*, Alexander Gusev, PhD1,2,3,14*, Gad Getz, PhD2,15,16,17* and Catherine J. Wu, MD1,2,3,10

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA
3Harvard Medical School, Boston, MA
4Department of Pathology, Brigham and Women's Hospital, Boston, MA
5Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
6Center of Molecular and Cellular Oncology, Yale School of Medicine, New Heaven, CT
7Harvard School of Public Health, Boston, MA
8Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
9Dana-Farber Cancer Institute, Boston, MA
10Department of Medicine, Brigham and Women's Hospital, Boston, MA
11Department of Health Technology, Technical University of Denmark, Lyngby, Denmark
12Department of Computer Science, Metropolitan College, Boston University, Boston, MA
13Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
14Division of Genetics, Brigham and Women’s Hospital, Boston, MA
15Center for Cancer Research, Massachusetts General Hospital, Boston, MA
16Department of Medicine, Harvard Medical School, Boston, MA
17Department of Pathology, Massachusetts General Hospital, Boston, MA

Gérard Socié, MD, PhD1*, Zhenyi Xue, PhD2*, Valkal Bhatt, PharmD2*, John Galvin, MD, MPH2* and Mohamad Mohty, MD PhD3

1Hôpital Saint-Louis, Paris, France
2Incyte Corporation, Wilmington, DE
3EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France

Leonardo Javier Arcuri1,2, Fabio Pires de Souza Santos, MD, PhD3, Lucila Kerbauy, MD, PhD4, Mariana Nassif Kerbauy, MD5*, Andreza Feitosa Ribeiro, MD, PhD6 and Nelson Hamerschlak, MD, PhD5

1Hospital Albert Einstein / HSCT Program, Hospital Albert Einstein, Sao Paulo, Brazil
2Instituto Nacional de Cancer, Rio De Janeiro, Brazil
3Oncology-Hematology Center, Hospital Israelita Albert Einstein, Sao Paulo, SP, AC, Brazil
4Hospital Israelita Albert Einstein, Sao Paulo, Brazil
5Hospital Israelita Albert Einstein, São Paulo, Brazil
6Hospital Israelita Albert Einstein, Sao Paulo, Sp, BRA

Hai-Xia Fu1*, Xueyan Sun2,3,4,5*, Yuanyuan Zhang6*, Tingting Han6*, Xiao-Dong Mo1*, Meng Lv, MD, PhD7, Fengrong Wang, MD8*, Chenhua Yan9*, Yu Wang10*, Jun Kong10*, Yuqian Sun, MD6*, Huan Chen1*, Yao Chen6*, Yu-Hong Chen1*, Ren Lin11*, Li Gao12*, Kaiyan Liu, MD, PhD13, Xiaohui Zhang10*, Xi Zhang, M.D., Ph.D.14*, Qifa Liu, MD15, Xiaojun Huang16* and Lanping Xu, MD, PhD10*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
2National Clinical Research Center for Haematologic Disease, Beijing, China
3Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China
4Collaborative Innovation Centre of Haematology, Peking University, Beijing, China
5Peking University People’s Hospital, Beijing, China
6Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of HSCT, Peking University, Beijing, China
7Peking University People's Hospital, Beijing, China
8Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
9Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
10Peking University People’s Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
11Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
12Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
13Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China., Beijing, China
14Department of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China
15Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
161Collaborative Innovation Centre of Hematology, Peking University, Beijing, China; 2Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China; 3Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, Beijing, China

María Queralt Salas, MD1*, Paola Charry2*, Nuria Martínez-Cibrian, MD3*, María Suárez-Lledó, MD3*, Luis Gerardo Rodríguez-Lobato, MD, PhD3*, Marc Brusosa4*, María Teresa Solano3*, Meritxell Nomdedeu, MD3*, Joan Cid5*, Miquel Lozano, PhD3*, Jordi Arcarons3*, Noemí Llobet6*, Laura Rosinol Dachs7*, Jordi Esteve, MD, PhD3, Álvaro Urbano-Ispizua, MD, PhD8*, Enric Carreras, MD, PhD9*, Francesc Fernández-Avilés, MD3*, Maria Carmen Martinez Munoz, PhD3* and Montserrat Rovira, MD, PhD3*

1Hematopoietic Transplantation Unit and Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
2Hospital Clinic de Barcelona, Barcelona, Spain
3Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
4University of Barcelona, Barcelona, Spain
5Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain
6Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clínic, Barcelona, Spain
7Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
8Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
9Josep Carreras Institute against leukemia (Campus Clinic), Barcelona, Spain

Jandin Alizee1*, Cecile Pochon2,3*, Arnaud Campidelli, MD4*, Maud D'Aveni, MD4*, Celine Kicki4*, Tshinguta Mbuyi5*, Marcelo De Carvalho Bittencourt, MD, PhD3,5*, Pascal Chastagner, MD, PhD2,3*, Pierre Feugier, MD, PhD3,4*, Simona Pagliuca, MD, PhD3,4 and Marie Thérèse Rubio, MD, PhD3,4*

1Pediatric Onco-hematology Department, Children’s Hospital, University Hospital of Nancy, VANDOEUVRE Les Nancy, France
2Pediatric Onco-hematology Department, Children’s Hospital, University Hospital of Nancy, Vandoeuvre, France
3IMoPa, University of Lorraine, Vandoeuvre, France
4Hematology Department, University Hospital of Nancy, Vandoeuvre, France
5Laboratory of Immunology, University Hospital of Nancy, Vandoeuvre, France

Katharina M Habenicht1,2*, Anna Bootz1*, Simon Schäfer2*, Ingrid Vasova, MD1*, Matthias Fante, MD3*, Andrea Schneider2*, Michael Rehli, PhD3,4*, Petra Hoffmann, PhD3,4*, Wolf Roesler, M.D.1*, Matthias Edinger, MD, PhD3,4*, Wolfgang Herr, MD3, Andreas Mackensen, MD1*, Daniel Wolff, MD3*, Julia Winkler, MD1* and Thomas H Winkler, PhD2*

1Department of Internal Medicine 5, University Hospital Erlangen, Erlangen, Germany
2Department of Biology, Divison of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
3Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
4Leibniz Institute for Immunotherapy, Regensburg, Germany

Daniel Drozdov, MD1,2, Dustin Bunch, PhD3*, Xianghua Luo, PhD4,5*, Michelle Van Hee, BS6*, Xiangyang Dong, PhD7*, Jessica Knight-Perry, MD, MS8*, Roshini S. Abraham, PhD3 and Christen L. Ebens, MD, MPH8

1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Aarau, Switzerland
2Division of Stem Cell Transplantation and Children’s Research Center, University Children's Hospital Zürich, Zürich, Switzerland
3Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH
4Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
5Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN
6Mayo Clinic, Rochester, MN
7Quest Diagnostics, Lewisville, TX
8Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN

Beatrice Clemenceau, PhD1*, Amandine Le Bourgeois, PhD2*, Thierry Guillaume, MD, PhD3*, Marianne Coste-Burel, MD, PhD4*, Pierre Peterlin, MD5*, Alice Garnier, MD6*, Maxime Jullien, MD7*, Jocelyn Ollier8*, Marie C Bene, PharmD, DPhil9* and Patrice Chevallier, MD6

1CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
2Clinical Hematology Department, Nantes University Hospital, Nantes, France
3CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
4Virology, Nantes University Hospital, Nantes, France
5Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
6Hematology Department, Nantes University Hospital, Nantes, France
7Clinical Hematology, Nantes University Hospital, NANTES, France
8INSERM, Nantes University Hospital, NANTES, France
9Hematology Biology, Nantes University Hospital, Nantes, France

Rebekah L. Wilson1*, Dong-Woo Kang2*, Paola Gonzalo-Encabo2*, Cami Christopher2*, Amber Normann, MS1*, Danny Nguyen2*, Mary K. Norris2*, Marilyn J. Hammer2*, Corey Cutler, MD, MPH, FRCPC3 and Christina M. Dieli-Conwright, PhD, MPH1

1Dana-Farber Cancer Institute, Boston, MA
2Dana-Farber Cancer Institute, Boston
3Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA

Ting Chen1*, Han Yao2*, Yuqing Liu3*, Lidan Zhu4*, Jia Liu3*, Liu Huanfeng5*, Shichun Gao6*, Lu Wang7*, Lu Zhao3*, Yimei Feng7*, Lei Gao8,9*, Xi Zhang, MD, PhD1* and Peiyan Kong10*

1Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
2Xinqiao Hospital, Chongqing, CHN
3Xinqiao hospital, Chongqing, China
4Medical center of Hematology, Xinqiao Hospital, Army medical University, Chongqing, China
5Medical center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
6Department of Hematology, Xinqiao Hospital, Army medical University, Chongqing, China
7Medical center of hematology, Xinqiao Hospital, Army Medical University, Chongqing, Chongqing, China
8Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China, Chongqing, China
9Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, chongqing, China
10Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China, Chongqing, China

Andy Ingram1*, Bronwen E. Shaw, MD, PhD2, Sharniece Covill3*, Manmeet Kaur, B.Pharm, MPH4* and Xingyue Huang, PhD5*

1Mallinckrodt Pharmaceuticals, Staines, ENG, United Kingdom
2CIBMTR Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3CIBMTR Center for International Blood and Marrow Transplant Research, Milwaukee, WI
4CIBMTR Centre for International Blood and Marrow Transplant Research, Milwaukee, WI
5Mallinckrodt Pharmaceuticals, Hampton, NJ

Michelle Chin, MS1, Judith A Shizuru, MD, PhD2, Lori Muffly, MD2, Parveen Shiraz, MD3, Laura J. Johnston, MD3, Robert Lowsky, MD3, Andrew R. Rezvani, MD3, Matthew J Frank, MD, PhD4, Sushma Bharadwaj, MD, MS2*, Wen-Kai Weng, MD, PhD3, Robert S. Negrin, MD2, David B. Miklos, MD, PhD2 and Sally Arai, MD5

1University of Central Florida College of Medicine, Orlando
2Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
3Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
4Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
5Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA

Eleni Gavriilaki, MD, PhD1, Panagiotis Dolgyras2*, Sotiria Dimou-Mpesikli3*, Aikaterini Poulopoulou4*, Christos Demosthenous, MD5, Evangelia Zachrou3*, Panagiotis Siasios4*, Despina Mallouri2*, Anna Vardi3*, Zoi Bousiou, MD, MSc6*, Alkistis Panteliadou, MD7*, Marianna Masmanidou7*, Chrysavgi Lalayanni2*, Evangelia Yannaki5*, Damianos Sotiropoulos2, Achilles Anagnostopoulos5, Timoleon Achilleas Vyzantiadis4* and Ioanna Sakellari8*

12nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
2Hematology Department – HCT Unit, George Papanicolaou Hospital, Thessaloniki, Greece
3G Papanicolaou Hospital, Thessaloniki, Greece
4Aristotle University of Thessaloniki, Thessaloniki, Greece
5Department of Hematology and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece
6Hematology Department-BMT Unit, G.Papanicolaou Hospital, Thessaloniki, Greece
7Hematology Department - BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
8Hematology Department and HCT Unit, George Papanikolaou General Hospital, THESSALONIKI, AL, Greece

Maria Stefania Infante, MD1,2*, Susan DeWolf, MD3, Roni Tamari, MD4,5, Parastoo B. Dahi, MD5,6, Yeon Joo Lee, MD, MPH7,8*, Ioannis Politikos, MD4,5, Juliet N. Barker, MBBS4,5, N. Esther Babady9*, Lakshmi Ramanathan, PhD10*, Susan Seo8*, Sergio A Giralt, MD4,11, Mini Kamboj12,13*, Miguel-Angel Perales, MD5,14 and Gunjan L. Shah, MD5,15*

1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Weill Cornell Medical College, New York, NY
6Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, new york, NY
8Department of Medicine, Weill Cornel Medical College, new york, NY
9Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Department of Medicine, Weill Cornell Medical College, New York
12Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Weill Cornel Medical College, new york, NY
14Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
15Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY

Paula Muñiz Sevilla1,2*, María Martínez-García2,3*, Mi Kwon, MD, PhD4,5*, Rebeca Bailén, MD1,2*, Gillen Oarbeascoa, MD2,6*, Diego Carbonell, Mr1,4*, Julia Suárez González2,7*, María Chicano Lavilla, PhD4,8*, Cristina Andres2,9*, Juan Carlos Triviño10*, Javier Anguita2,11*, José Luis Díez-Martín, MD, PhD2,12, Pablo Martínez Olmos2,3*, Carolina Martinez-Laperche1,2* and Ismael Buño, PhD1,4,7,13*

1Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain
2Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain
3Department of Signal Theory and Communications, Universidad Carlos III de Madrid, Madrid, Spain
4Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain
5Hematology Department, Gregorio Marañón General University Hospital, Madrid, Spain
6Department of Hematology, Gregorio Marañón General University Hospital (HGUGM), Madrid, Spain
7Genomics Unit, Gregorio Marañón General University Hospital, IiSGM, Madrid, Spain
8Department of Hematology, Gregorio Marañón General University Hospital (HGUGM), MADRID, Spain
9Genomics Unit, Gregorio Marañón General University Hospital (HGUGM), Madrid, Spain
10Bioinformatics, Sistemas Genómicos, Valencia, Spain
11hematology department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
12Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
13Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain

Daniel Drozdov, MD1,2, Susie L. Long, PharmD3*, Ashish O. Gupta, MBBS, MPH4, Troy C. Lund, MD, PhD, MS4, Jaap Jan Boelens, MD, PhD5 and Paul J. Orchard, MD4*

1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Aarau, Switzerland
2Division of Stem Cell Transplantation and Children’s Research Center, University Children's Hospital Zürich, Zürich, Switzerland
3Acute Care Pharmacy Services, University of Minnesota Masonic Children's Hospital, Minneapolis, MN
4Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN
5Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH